Revance Therapeutics, Inc.

NASDAQ:RVNC

5.85 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 65.38951.93669.79956.77658.13449.33149.92129.01528.36825.26125.9519.74518.80413.29911.1333.8350.2990.0580.0890.04600.2780.4872.3620.6860.1930.0370.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.1580.3090.1580.0750.0750.117
Cost of Revenue 19.06416.89218.89119.41321.30716.17123.51510.7369.5237.8937.8815.8865.4264.2173.6631.0850.02139.79420.69125.8470000000000000000000000-0.2330000
Gross Profit 46.32535.04450.90837.36336.82733.1626.40618.27918.84517.36818.06913.85913.3789.0827.472.750.278-39.736-20.602-25.80100.2780.4872.3620.6860.1930.0370.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.0750.1580.5420.1580.0750.0750.117
Gross Profit Ratio 0.7080.6750.7290.6580.6330.6720.5290.630.6640.6880.6960.7020.7110.6830.6710.7170.93-685.103-231.483-560.89101111111111111111111111.7541111
Reseach & Development Expenses 15.48413.62719.7213.0622.80723.17719.54126.10324.91330.72929.46830.09529.44127.25126.78229.1327.10339.79427.49325.84725.52623.99525.53221.84822.87122.23921.00421.64318.30719.40912.5310.29615.19212.36414.95613.01610.3039.2549.1298.68.117.5516.2396.2847.7827.52716.879
General & Administrative Expenses 65.2170-169.12867.72976.34463.86990.7764.73746.82943.941-121.21551.7749.67948.07351.88147.51129.60621.22418.76616.73913.59612.9113.35814.15512.73413.61611.8879.1488.6097.7547.17.5027.0187.4556.9055.8276.365.9964.7935.34.8574.09300000
Selling & Marketing Expenses 0.1230253.42401.042.142-25.533000166.420003.9380.6720000000000000000000000-0.00100000000
SG&A 65.41667.47884.29667.72977.38466.01165.23764.73746.82943.94146.43651.7749.67948.07355.81948.18329.60621.22418.76616.73913.59612.9113.35814.15512.73413.61611.8879.1488.6097.7547.17.5027.0187.4556.9055.8276.365.9964.7925.34.8574.0933.0032.1423.6412.2251.614
Other Expenses -0.453-0.4380.218-0.223-0.5992.00416.254.9234.9454.919-0.151-0.146-0.357-0.105-0.186-0.146-0.134-0.126-0.133-0.130.115-0.155-0.147-0.144-0.172-0.319-0.138-0.128-0.132-0.126-0.128-0.138-0.143-0.125-0.106-0.098-0.076-0.047-0.162-0.005-0.0680-0.364-0.038-0.0040.002-0.021
Operating Expenses 80.981.105104.01682.742102.32691.192101.02895.76376.68779.58979.67386.58283.71579.09485.43979.87857.38361.01846.25942.58639.12236.90538.8936.00335.60535.85532.89130.79126.91627.16319.6317.79822.2119.81921.86118.84316.66315.2513.92113.912.96711.6449.2428.42611.4239.75218.493
Operating Income -34.575-46.061-53.108-139.293-65.499-58.032-74.622-77.484-57.842-62.221-61.604-72.723-70.337-70.012-77.969-77.128-57.105-60.96-46.17-42.54-39.122-36.627-38.403-33.641-34.919-35.662-35.781-30.716-26.841-27.088-26.666-17.723-24.084-19.744-21.786-18.768-16.588-15.175-13.846-13.825-12.892-11.486-8.933-8.268-11.348-9.677-18.376
Operating Income Ratio -0.529-0.887-0.761-2.453-1.127-1.176-1.495-2.67-2.039-2.463-2.374-3.683-3.741-5.264-7.003-20.112-190.987-1,051.034-518.764-924.7830-131.752-78.856-14.243-50.902-184.777-967.054-409.547-357.88-361.173-355.547-236.307-321.12-263.253-290.48-250.24-221.173-202.333-184.613-184.333-171.893-72.696-28.909-52.329-151.307-129.027-157.06
Total Other Income Expenses Net -2.894-3.464-2.591-94.137-0.599-1.761-71.33-6.509-3.593-2.1210.008-0.166-0.376-0.164-0.104-0.208-0.193-0.216-0.193-0.1980.136-0.247-0.137-0.189-0.242-0.353-3.445-0.172-0.239-0.186-7.252-0.305-2.505-0.139-0.039-0.0850.013-0.089-0.0560.062-0.144-0.1010.552-0.2640.0070.64417.185
Income Before Tax -37.469-49.525-55.699-140.876-67.318-59.793-145.952-83.993-61.435-64.342-63.098-74.376-72.197-71.639-81.029-81.257-60.59-61.833-45.326-41.409-37.39-35.304-37.616-32.834-34.08-35.037-35.906-30.651-26.874-27.156-26.802-17.978-24.602-19.888-22.094-19.175-16.805-15.402-14.212-13.977-13.302-21.426-10.079-8.883-11.829-21.657-10.901
Income Before Tax Ratio -0.573-0.954-0.798-2.481-1.158-1.212-2.924-2.895-2.166-2.547-2.432-3.767-3.839-5.387-7.278-21.188-202.642-1,066.086-509.281-900.1960-126.993-77.24-13.901-49.679-181.539-970.432-408.68-358.32-362.08-357.36-239.707-328.027-265.173-294.587-255.667-224.067-205.36-189.493-186.36-177.36-135.608-32.618-56.222-157.72-288.76-93.171
Income Tax Expense 0.0013.6271.3750.3-0.0646.258-1.40.70.0610.0441.5731.4251.2121.455-2.724.1884.1220.1-0.89-0.13-0.675-0.1553-0.144-1.428-0.665-0.492-0.0240.0090.067-0.280.1180.1430.19-0.159-0.219-0.341-0.413-0.316-0.3190.1999.8410.8380.3130.48612.6269.688
Net Income -37.473-53.152-55.699-141.176-67.318-66.051-144.552-84.693-61.496-64.386-63.098-74.376-72.197-71.639-78.309-81.257-60.59-61.933-45.326-41.409-37.39-35.304-40.616-32.834-34.08-35.037-35.906-30.651-26.874-27.156-26.802-17.978-24.602-19.888-22.094-19.175-16.805-15.402-14.212-13.977-13.302-21.426-10.079-8.883-11.829-21.657-10.901
Net Income Ratio -0.573-1.023-0.798-2.487-1.158-1.339-2.896-2.919-2.168-2.549-2.432-3.767-3.839-5.387-7.034-21.188-202.642-1,067.81-509.281-900.1960-126.993-83.4-13.901-49.679-181.539-970.432-408.68-358.32-362.08-357.36-239.707-328.027-265.173-294.587-255.667-224.067-205.36-189.493-186.36-177.36-135.608-32.618-56.222-157.72-288.76-93.171
EPS -0.36-0.58-0.62-1.63-0.8-0.81-1.8-1.17-0.88-0.94-0.93-1.1-1.07-1.08-1.24-1.34-1.12-1.15-0.99-0.96-0.86-0.85-1.12-0.91-0.94-0.97-1.14-1.01-0.9-0.94-0.96-0.64-0.88-0.71-0.84-0.81-0.71-0.65-0.6-0.6-0.69-1.93-0.57-1.24-1.65-3.02-1.52
EPS Diluted -0.36-0.58-0.62-1.63-0.8-0.81-1.8-1.17-0.88-0.94-0.93-1.1-1.07-1.08-1.24-1.34-1.12-1.15-0.99-0.96-0.86-0.85-1.12-0.91-0.94-0.97-1.14-1.01-0.9-0.94-0.95-0.64-0.88-0.71-0.83-0.81-0.71-0.65-0.6-0.6-0.69-1.93-0.57-1.24-1.65-3.02-1.52
EBITDA -33.146-44.08-51.689-39.744-60.815-53.292-56.161-67.418-50.891-56.991-57.915-67.635-65.566-65.779-73.863-74.296-54.862-58.856-45.266-40.607-37.411-34.584-37.626-32.345-34.849-34.959-32.581-30.129-26.261-26.546-19.453-17.186-21.599-19.215-21.805-18.798-16.615-15.195-13.982-13.816-12.428-10.996-9.297-7.831-10.893-9.222-17.951
EBITDA Ratio -0.507-0.849-0.741-0.7-1.046-1.08-1.125-2.324-1.794-2.256-2.232-3.425-3.487-4.946-6.635-19.373-183.485-1,014.759-508.607-882.7610-124.403-77.261-13.694-50.8-181.135-880.568-401.72-350.147-353.947-259.373-229.147-287.987-256.2-290.733-250.64-221.533-202.6-186.427-184.213-165.707-69.595-30.087-49.563-145.24-122.96-153.427